Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising/recruitment
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Recently published
    • Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Recently published
  • In-Press Preview
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising/recruitment
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a letter
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need Help? E-mail the JCI Insight
  • Top
  • Abstract
  • Supplemental material
  • Version history
  • Article usage
  • Citations to this article
Advertisement

ResearchIn-Press PreviewImmunology Open Access | 10.1172/jci.insight.140273

Constitutive WASp activation leads to abnormal cytotoxic cells with increased response against tumors

Joanna S. Kritikou,1 Mariana M.S. Oliveira,1 Julien Record,1 Mezida B. Saeed,1 Saket M. Nigam,1 Minghui He,1 Marton Keszei,1 Arnika K. Wagner,2 Hanna Brauner,1 Anton Sendel,1 Saikiran K. Sedimbi,1 Stamatina Rentouli,1 David P. Lane,1 Scott B. Snapper,3 Klas Kärre,1 Peter Vandenberghe,4 Jordan S. Orange,5 and Lisa S. Westerberg1

1Department of Microbiology, Tumor, and Cell Biology, Karolinska Institutet, Stockholm, Sweden

2Department of Medicine, Karolinska Institutet, Stockholm, Sweden

3Gastroenterology Division, Children's Hospital, Harvard Medical School, Boston, United States of America

4Center for Human Genetics, Katholieke Universiteit Leuven, Leuven, Belgium

5Department of Pediatrics, Vagelos College of Physicians and Surgeons, New York, United States of America

Find articles by Kritikou, J. in: JCI | PubMed | Google Scholar

1Department of Microbiology, Tumor, and Cell Biology, Karolinska Institutet, Stockholm, Sweden

2Department of Medicine, Karolinska Institutet, Stockholm, Sweden

3Gastroenterology Division, Children's Hospital, Harvard Medical School, Boston, United States of America

4Center for Human Genetics, Katholieke Universiteit Leuven, Leuven, Belgium

5Department of Pediatrics, Vagelos College of Physicians and Surgeons, New York, United States of America

Find articles by Oliveira, M. in: JCI | PubMed | Google Scholar

1Department of Microbiology, Tumor, and Cell Biology, Karolinska Institutet, Stockholm, Sweden

2Department of Medicine, Karolinska Institutet, Stockholm, Sweden

3Gastroenterology Division, Children's Hospital, Harvard Medical School, Boston, United States of America

4Center for Human Genetics, Katholieke Universiteit Leuven, Leuven, Belgium

5Department of Pediatrics, Vagelos College of Physicians and Surgeons, New York, United States of America

Find articles by Record, J. in: JCI | PubMed | Google Scholar |

1Department of Microbiology, Tumor, and Cell Biology, Karolinska Institutet, Stockholm, Sweden

2Department of Medicine, Karolinska Institutet, Stockholm, Sweden

3Gastroenterology Division, Children's Hospital, Harvard Medical School, Boston, United States of America

4Center for Human Genetics, Katholieke Universiteit Leuven, Leuven, Belgium

5Department of Pediatrics, Vagelos College of Physicians and Surgeons, New York, United States of America

Find articles by Saeed, M. in: JCI | PubMed | Google Scholar

1Department of Microbiology, Tumor, and Cell Biology, Karolinska Institutet, Stockholm, Sweden

2Department of Medicine, Karolinska Institutet, Stockholm, Sweden

3Gastroenterology Division, Children's Hospital, Harvard Medical School, Boston, United States of America

4Center for Human Genetics, Katholieke Universiteit Leuven, Leuven, Belgium

5Department of Pediatrics, Vagelos College of Physicians and Surgeons, New York, United States of America

Find articles by Nigam, S. in: JCI | PubMed | Google Scholar |

1Department of Microbiology, Tumor, and Cell Biology, Karolinska Institutet, Stockholm, Sweden

2Department of Medicine, Karolinska Institutet, Stockholm, Sweden

3Gastroenterology Division, Children's Hospital, Harvard Medical School, Boston, United States of America

4Center for Human Genetics, Katholieke Universiteit Leuven, Leuven, Belgium

5Department of Pediatrics, Vagelos College of Physicians and Surgeons, New York, United States of America

Find articles by He, M. in: JCI | PubMed | Google Scholar

1Department of Microbiology, Tumor, and Cell Biology, Karolinska Institutet, Stockholm, Sweden

2Department of Medicine, Karolinska Institutet, Stockholm, Sweden

3Gastroenterology Division, Children's Hospital, Harvard Medical School, Boston, United States of America

4Center for Human Genetics, Katholieke Universiteit Leuven, Leuven, Belgium

5Department of Pediatrics, Vagelos College of Physicians and Surgeons, New York, United States of America

Find articles by Keszei, M. in: JCI | PubMed | Google Scholar |

1Department of Microbiology, Tumor, and Cell Biology, Karolinska Institutet, Stockholm, Sweden

2Department of Medicine, Karolinska Institutet, Stockholm, Sweden

3Gastroenterology Division, Children's Hospital, Harvard Medical School, Boston, United States of America

4Center for Human Genetics, Katholieke Universiteit Leuven, Leuven, Belgium

5Department of Pediatrics, Vagelos College of Physicians and Surgeons, New York, United States of America

Find articles by Wagner, A. in: JCI | PubMed | Google Scholar |

1Department of Microbiology, Tumor, and Cell Biology, Karolinska Institutet, Stockholm, Sweden

2Department of Medicine, Karolinska Institutet, Stockholm, Sweden

3Gastroenterology Division, Children's Hospital, Harvard Medical School, Boston, United States of America

4Center for Human Genetics, Katholieke Universiteit Leuven, Leuven, Belgium

5Department of Pediatrics, Vagelos College of Physicians and Surgeons, New York, United States of America

Find articles by Brauner, H. in: JCI | PubMed | Google Scholar

1Department of Microbiology, Tumor, and Cell Biology, Karolinska Institutet, Stockholm, Sweden

2Department of Medicine, Karolinska Institutet, Stockholm, Sweden

3Gastroenterology Division, Children's Hospital, Harvard Medical School, Boston, United States of America

4Center for Human Genetics, Katholieke Universiteit Leuven, Leuven, Belgium

5Department of Pediatrics, Vagelos College of Physicians and Surgeons, New York, United States of America

Find articles by Sendel, A. in: JCI | PubMed | Google Scholar |

1Department of Microbiology, Tumor, and Cell Biology, Karolinska Institutet, Stockholm, Sweden

2Department of Medicine, Karolinska Institutet, Stockholm, Sweden

3Gastroenterology Division, Children's Hospital, Harvard Medical School, Boston, United States of America

4Center for Human Genetics, Katholieke Universiteit Leuven, Leuven, Belgium

5Department of Pediatrics, Vagelos College of Physicians and Surgeons, New York, United States of America

Find articles by Sedimbi, S. in: JCI | PubMed | Google Scholar |

1Department of Microbiology, Tumor, and Cell Biology, Karolinska Institutet, Stockholm, Sweden

2Department of Medicine, Karolinska Institutet, Stockholm, Sweden

3Gastroenterology Division, Children's Hospital, Harvard Medical School, Boston, United States of America

4Center for Human Genetics, Katholieke Universiteit Leuven, Leuven, Belgium

5Department of Pediatrics, Vagelos College of Physicians and Surgeons, New York, United States of America

Find articles by Rentouli, S. in: JCI | PubMed | Google Scholar |

1Department of Microbiology, Tumor, and Cell Biology, Karolinska Institutet, Stockholm, Sweden

2Department of Medicine, Karolinska Institutet, Stockholm, Sweden

3Gastroenterology Division, Children's Hospital, Harvard Medical School, Boston, United States of America

4Center for Human Genetics, Katholieke Universiteit Leuven, Leuven, Belgium

5Department of Pediatrics, Vagelos College of Physicians and Surgeons, New York, United States of America

Find articles by Lane, D. in: JCI | PubMed | Google Scholar |

1Department of Microbiology, Tumor, and Cell Biology, Karolinska Institutet, Stockholm, Sweden

2Department of Medicine, Karolinska Institutet, Stockholm, Sweden

3Gastroenterology Division, Children's Hospital, Harvard Medical School, Boston, United States of America

4Center for Human Genetics, Katholieke Universiteit Leuven, Leuven, Belgium

5Department of Pediatrics, Vagelos College of Physicians and Surgeons, New York, United States of America

Find articles by Snapper, S. in: JCI | PubMed | Google Scholar |

1Department of Microbiology, Tumor, and Cell Biology, Karolinska Institutet, Stockholm, Sweden

2Department of Medicine, Karolinska Institutet, Stockholm, Sweden

3Gastroenterology Division, Children's Hospital, Harvard Medical School, Boston, United States of America

4Center for Human Genetics, Katholieke Universiteit Leuven, Leuven, Belgium

5Department of Pediatrics, Vagelos College of Physicians and Surgeons, New York, United States of America

Find articles by Kärre, K. in: JCI | PubMed | Google Scholar

1Department of Microbiology, Tumor, and Cell Biology, Karolinska Institutet, Stockholm, Sweden

2Department of Medicine, Karolinska Institutet, Stockholm, Sweden

3Gastroenterology Division, Children's Hospital, Harvard Medical School, Boston, United States of America

4Center for Human Genetics, Katholieke Universiteit Leuven, Leuven, Belgium

5Department of Pediatrics, Vagelos College of Physicians and Surgeons, New York, United States of America

Find articles by Vandenberghe, P. in: JCI | PubMed | Google Scholar |

1Department of Microbiology, Tumor, and Cell Biology, Karolinska Institutet, Stockholm, Sweden

2Department of Medicine, Karolinska Institutet, Stockholm, Sweden

3Gastroenterology Division, Children's Hospital, Harvard Medical School, Boston, United States of America

4Center for Human Genetics, Katholieke Universiteit Leuven, Leuven, Belgium

5Department of Pediatrics, Vagelos College of Physicians and Surgeons, New York, United States of America

Find articles by Orange, J. in: JCI | PubMed | Google Scholar |

1Department of Microbiology, Tumor, and Cell Biology, Karolinska Institutet, Stockholm, Sweden

2Department of Medicine, Karolinska Institutet, Stockholm, Sweden

3Gastroenterology Division, Children's Hospital, Harvard Medical School, Boston, United States of America

4Center for Human Genetics, Katholieke Universiteit Leuven, Leuven, Belgium

5Department of Pediatrics, Vagelos College of Physicians and Surgeons, New York, United States of America

Find articles by Westerberg, L. in: JCI | PubMed | Google Scholar |

Published February 23, 2021 - More info

JCI Insight. https://doi.org/10.1172/jci.insight.140273.
Copyright © 2021, Kritikou et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Published February 23, 2021 - Version history
View PDF
Abstract

X-linked neutropenia (XLN) is caused by gain-of-function mutations in the actin regulator Wiskott-Aldrich Syndrome protein (WASp). XLN patients have reduced numbers of cytotoxic cells in peripheral blood, however, their capacity to kill tumor cells remains to be determined. Here, we examined NK and T cells from two XLN patients harboring the activating WASpL270P mutation. XLN patient NK and T cells had increased Granzyme B content and elevated degranulation and IFNγ production when compared to healthy control cells. Murine WASpL272P NK and T cells formed stable synapses with YAC-1 tumor cells and anti-CD3/CD28 coated beads, respectively. WASpL272P T cells mice had normal degranulation and cytokine response whereas WASpL272P NK cells showed an enhanced response. Imaging experiments revealed that while WASpL272P CD8 T cells had increased accumulation of actin upon TCR activation, WASpL272P NK cells had normal actin accumulation at lytic synapses triggered through NKp46 signaling but had impaired response to LFA-1 engagement. When compared to WT mice, WASpL272P mice showed reduced growth of B16 melanoma and increased capacity to reject MHC class I-deficient cells. Together, our data suggests that cytotoxic cells with constitutively active WASp have an increased capacity to respond to and kill tumor cells.

Graphical Abstract
graphical abstract
Supplemental material

View

Version history
  • Version 1 (February 23, 2021): In-Press Preview

Article tools

  • View PDF
  • Download citation information
  • Send a letter
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need Help? E-mail the JCI Insight

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Supplemental material
  • Version history
Advertisement
Advertisement
Follow JCI Insight:
Copyright © 2021 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts